|
Volumn 350, Issue 6267, 2015, Pages 1453-
|
Camel vaccine offers hope to stop MERS: Vaccinated animals shed less virus, but is that good enough to prevent human outbreaks?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS VACCINE;
RNA VACCINE;
UNCLASSIFIED DRUG;
VIRUS VACCINE;
BIOSAFETY;
CAMEL;
CORONAVIRUS INFECTION;
DNA SEQUENCE;
DROMEDARY;
EPIDEMIC;
HUMAN;
INFECTION CONTROL;
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS;
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS INFECTION;
NONHUMAN;
NOTE;
PANDEMIC;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
SEVERE ACUTE RESPIRATORY SYNDROME;
VIRUS GENOME;
ANIMAL;
CORONAVIRUS INFECTIONS;
DISEASE OUTBREAKS;
GENETICS;
IMMUNOLOGY;
VETERINARY;
VIROLOGY;
VIRUS SHEDDING;
ANIMALIA;
ANIMALS;
CAMELS;
CLINICAL TRIALS, PHASE I AS TOPIC;
CORONAVIRUS INFECTIONS;
DISEASE OUTBREAKS;
GENOME, VIRAL;
HUMANS;
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS;
SEQUENCE ANALYSIS, DNA;
VIRAL VACCINES;
VIRUS SHEDDING;
|
EID: 84950312290
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.350.6267.1453 Document Type: Note |
Times cited : (6)
|
References (0)
|